entity

liproxstatin-1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about liproxstatin-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections
1Hypotheses
1Analyses
15Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (15)

TargetRelationTypeStr
Ferroptosisinhibitsprocess0.95
Apoptosisinhibitsprocess0.90
Pyroptosisinhibitsprocess0.90
Necroptosisinhibitsprocess0.90
Metabolic Dysfunction-Associated Fatty Liver Diseasetreatsdisease0.90

Incoming (1)

SourceRelationTypeStr
ACSL4pathway_target_ofgene0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Liproxstatin-1 as Mechanism-Validation Tool for Ferroptosis 0.580 neurodegeneration Can ferroptosis inhibitors prevent BBB d

Mentioning Analyses (1)

Scientific analyses that reference this entity

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

neurodegeneration | 2026-04-25 | 7 hypotheses Top: 0.760

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Can ferroptosis inhibitors prevent BBB disruption and edema formation after card

closed · Rounds: 4 · Score: 0.73 · 2026-04-25

Related Research

Hypotheses and analyses mentioning liproxstatin-1 in their description or question text

No additional research found